Brief: Xuanzhu Biopharmaceutical Announces Commercial Cooperation With Innobic For Birecociclib
03/09/2026 11:27
BRIEF-Xuanzhu Biopharmaceutical Announces Commercial Cooperation With Innobic For Birecociclib Sept 3 (Reuters) - Xuanzhu Biopharmaceutical Co Ltd 2575.HK:
ANNOUNCES COMMERCIAL COOPERATION WITH INNOBIC FOR BIRECOCICLIB IN THAILAND
GRANTS EXCLUSIVE COMMERCIALISATION RIGHTS FOR BIRECOCICLIB IN THAILAND TO INNOBIC (ASIA) AND ZAOAN INTERNATIONAL
Further company coverage: 2575.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Xuanzhu Biopharmaceutical
See all newsBrief: Xuanzhu Biopharmaceutical Announces Commercial Cooperation With Innobic For Birecociclib
Xuanzhu Biopharmaceutical climbs to three-week high on approval for drug clinical trial
Brief: Xuanzhu Biopharmaceutical Says Approved To Initiate Phase Iii Trial Of Anaprazole Sodium
China's Xuanzhu set for best day in 6 months on drug deal with Boston Oncology
Brief: Xuanzhu Biopharmaceutical Enters Licensing Agreement With Boston Oncology